SpyGlass Pharma Inc (SGP)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$34.08-1.07%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · SGP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Operating Expenses & Income | |||
| R&D Expenses | 29.2 | 20.0 | — |
| Operating Income | (41.4) | (27.1) | — |
| Earnings from Continuing Operations | |||
| Interest & Investment Income | 3.1 | 1.3 | — |
| Other Non-Operating Income / Expenses | 1.6 | (2.1) | — |
| EBT, Incl. Unusual Items | (39.9) | (29.2) | — |
| Income Tax Expense | — | 0.0 | — |
| Net Income | |||
| Net Income | (39.9) | (29.2) | — |
| Per Share | |||
| Basic EPS | (17.98) | (16.31) | — |
| Diluted EPS | (17.98) | (16.31) | — |
| Basic Weighted Avg Shares | 2.2 | 1.8 | — |
| Diluted Weighted Avg Shares | 2.2 | 1.8 | — |
| Supplemental | |||
| EBIT | (41.4) | (27.1) | — |
| Effective Tax Rate | — | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.